Zebrafish embryos and larvae: A new generation of disease models and drug screens

Birth Defects Research Part C - Embryo Today: Reviews

Volumn 93, Issue 2, 2011, Pages 115-133

  Ali, Shaukat ^a   Champagne, Danielle L ^a,b   Spaink, Herman P ^c   Richardson, Michael K ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

^c LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Behavior; Disease model; Embryo; Larvae; Screens; Toxicology; Zebrafish

Indexed keywords

ALCOHOL; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BUSPIRONE; DIAZEPAM;

ALZHEIMER DISEASE; ANGIOGENESIS; ANIMAL BEHAVIOR; ANXIETY; CAVERNOUS HEMANGIOMA; CHORION; CULTURE TECHNIQUE; CYTOTOXICITY; DISEASE MODEL; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG SCREENING; EMBRYO; ENTERITIS; EPILEPSY; FETAL ALCOHOL SYNDROME; FLUORESCENCE; HEART ARRHYTHMIA; HEART FUNCTION; KIDNEY POLYCYSTIC DISEASE; LABORATORY APPARATUS, EQUIPMENT AND SUPPLIES; LARVA; LIGHT DARK CYCLE; MEDICAL RESEARCH; MICROFLUIDICS; NEOPLASM; NONHUMAN; OPEN FIELD TEST; PARKINSON DISEASE; POLYCYTHEMIA VERA; PORPHYRIA VARIEGATA; PREDICTIVE VALUE; PRENATAL EXPOSURE; PRIORITY JOURNAL; QT PROLONGATION; REVIEW; ROBOTICS; SHORT QT INTERVAL; TERATOGENICITY; TOXICITY TESTING; TUBERCULOSIS; VALIDATION PROCESS; VISUOMOTOR COORDINATION; WAARDENBURG SYNDROME; ZEBRA FISH;

ANIMALS; BIOMEDICAL RESEARCH; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; DRUG EVALUATION, PRECLINICAL; EMBRYO CULTURE TECHNIQUES; EMBRYO, NONMAMMALIAN; FEMALE; FETAL ALCOHOL SYNDROME; FLUORESCENCE; LARVA; MICROFLUIDICS; PREGNANCY; TOXICITY TESTS; TUBERCULOSIS; ZEBRAFISH;

DANIO RERIO; RODENTIA;

EID: 79958848236     PISSN: 1542975X     EISSN: 15429768     Source Type: Journal    
DOI: 10.1002/bdrc.20206     Document Type: Review

References (212)

1. Agid Y, Buzsaki G, Diamond DM, et al. 2007. How can drug discovery for psychiatric disorders be improved? Nat Rev Drug Discov 6: 189-201.
2. Ali S, Champagne DL, Alia A, Richardson MK. 2011. Large-scale analysis of acute ethanol exposure in zebrafish development: a critical time window and resilience. PLoS ONE. In press.
3. Andreu N, Zelmer A, Fletcher T, et al. 2010. Optimisation of bioluminescent reporters for use with mycobacteria. PLoS One 5: e10777.
4. Arenzana FJ, Carvan MJIII, Aijon J, et al. 2006. Teratogenic effects of ethanol exposure on zebrafish visual system development. Neurotoxicol Teratol 28: 342-348.
5. Arslanova D, Yang T, Xu X, et al. 2010. Phenotypic analysis of images of zebrafish treated with Alzheimer's gamma-secretase inhibitors. BMC Biotechnol 10: 24.
6. Barnes DM. 1986. Tight money squeezes out animal models. Science 232: 309-311.
7. Barros TP, Alderton WK, Reynolds HM, et al. 2008. Zebrafish: an emerging technology for in vivo pharmacological assessment to identify potential safety liabilities in early drug discovery. Br J Pharmacol 154: 1400-1413.
8. Berghmans S, Butler P, Goldsmith P, et al. 2008. Zebrafish based assays for the assessment of cardiac, visual and gut function-potential safety screens for early drug discovery. JPharmacol Toxicol Methods 58: 59-68.
9. Berghmans S, Hunt J, Roach A, Goldsmith P. 2007. Zebrafish offer the potential for a primary screen to identify a wide variety of potential anticonvulsants. Epilepsy Res 75: 18-28.
10. Berghmans S, Jette C, Langenau D, et al. 2005. Making waves in cancer research: new models in the zebrafish. Biotechniques 39: 227-237.
11. Best JD, Alderton WK. 2008. Zebrafish: an in vivo model for the study of neurological diseases. Neuropsychiatr Dis Treat 4: 567-576.
12. Best JD, Berghmans S, Hunt JJ, et al. 2008. Non-associative learning in larval zebrafish. Neuropsychopharmacology 33: 1206-1215.
13. Bianchini P, Diaspro A. 2008. Three-dimensional (3D) backward and forward second harmonic generation (SHG) microscopy of biological tissues. J Biophotonics 1: 443-450.
14. Bilotta J, Barnett JA, Hancock L, Saszik S. 2004. Ethanol exposure alters zebrafish development: a novel model of fetal alcohol syndrome. Neurotoxicol Teratol 26: 737-743.
15. Bilotta J, Saszik S, Givin CM, et al. 2002. Effects of embryonic exposure to ethanol on zebrafish visual function. Neurotoxicol Teratol 24: 759-766.
16. Blader P, Strahle U. 1998. Ethanol impairs migration of the prechordal plate in the zebrafish embryo. Dev Biol 201: 185-201.
17. Blaser RE, Chadwick L, McGinnis GC. 2010. Behavioral measures of anxiety in zebrafish (Danio rerio). Behav Brain Res 208: 56-62.
18. Bourin M, Hascoet M. 2003. The mouse light/dark box test. Eur J Pharmacol 463: 55-65.
19. Bouvrette DJ, Sittaramane V, Heidel JR, et al. 2010. Knockdown of bicaudal C in zebrafish (Danio rerio) causes cystic kidneys: a nonmammalian model of polycystic kidney disease. Comp Med 60: 96-106.
20. Brannen KC, Panzica-Kelly JM, Danberry TL, Augustine-Rauch KA. 2010. Development of a zebrafish embryo teratogenicity assay and quantitative prediction model. Birth Defects Res B Dev Reprod Toxicol 89: 66-77.
21. Braunbeck T, Boettcher M, Hollert H, et al. 2005. Towards an alternative for the acute fish LC(50) test in chemical assessment: the fish embryo toxicity test goes multi-species-an update. ALTEX 22: 87-102.
22. Brend T, Holley SA. 2009. Zebrafish whole mount high-resolution double fluorescent in situ hybridization. J Vis Exp 25. p ii: 1229. doi: 10.3791/1229.
23. Bretaud S, Allen C, Ingham PW, Bandmann O. 2007. p53-dependent neuronal cell death in a DJ-1-deficient zebrafish model of Parkinson's disease. J Neurochem 100: 1626-1635.
24. Bretaud S, Lee S, Guo S. 2004. Sensitivity of zebrafish to environmental toxins implicated in Parkinson's disease. Neurotoxicol Teratol 26: 857-864.
25. Brittijn SA, Duivesteijn SJ, Belmamoune M, et al. 2009. Zebrafish development and regeneration: new tools for biomedical research. Int J Dev Biol 53: 835-850.
26. Bull J, Levin B. 2000. Perspectives: microbiology. Mice are not furry petri dishes. Science 287: 1409-1410.
27. Burgess HA, Granato M. 2007. Modulation of locomotor activity in larval zebrafish during light adaptation. J Exp Biol 210: 2526-2539.
28. Burne T, Scott E, van SB, et al. 2011. Big ideas for small brains: what can psychiatry learn from worms, flies, bees and fish? Mol Psychiatry 16: 7-16.
29. Busquet F, Nagel R, von LF, et al. 2008. Development of a new screening assay to identify proteratogenic substances using zebrafish danio rerio embryo combined with an exogenous mammalian metabolic activation system (mDarT). Toxicol Sci 104: 177-188.
30. Cachat J, Canavello P, Elegante M, et al. 2010a. Modeling withdrawal syndrome in zebrafish. Behav Brain Res 208: 371-376.
31. Cachat J, Stewart A, Grossman L, et al. 2010b. Measuring behavioral and endocrine responses to novelty stress in adult zebrafish. Nat Protoc 5: 1786-1799.
32. Campagnola PJ, Clark HA, Mohler WA, et al. 2001. Second-harmonic imaging microscopy of living cells. J Biomed Opt 6: 277-286.
33. Campos C, Kamiya M, Banala S, et al. 2011. Labelling cell structures and tracking cell lineage in zebrafish using SNAP-tag. Dev Dyn 240: 820-827.
34. Canaple L, Beuf O, Armenean M, et al. 2008. Fast screening of paramagnetic molecules in zebrafish embryos by MRI. NMR Biomed 21: 129-137.
35. Carvalho R, de SJ, Stockhammer OW, et al. 2011. A high-throughput screen for tuberculosis progression. PLoS One 6: e16779.
36. Carvan MJIII, Loucks E, Weber DN, Williams FE. 2004. Ethanol effects on the developing zebrafish: neurobehavior and skeletal morphogenesis. Neurotoxicol Teratol 26: 757-768.
37. Champagne DL, de Kloet ER, Joels M. 2009. Fundamental aspects of the impact of glucocorticoids on the (immature) brain. Semin Fetal Neonatal Med 14: 136-142.
38. Champagne DL, Hoefnagels CC, de Kloet RE, Richardson MK. 2010. Translating rodent behavioral repertoire to zebrafish (Danio rerio): relevance for stress research. Behav Brain Res 214: 332-342.
39. Chi NC, Bussen M, Brand-Arzamendi K, et al. 2010. Cardiac conduction is required to preserve cardiac chamber morphology. Proc Natl Acad Sci USA 107: 14662-14667.
40. Chi NC, Shaw RM, Jungblut B, et al. 2008. Genetic and physiologic dissection of the vertebrate cardiac conduction system. PLoS Biol 6: e109.
41. Choleris E, Thomas AW, Kavaliers M, Prato FS. 2001. A detailed ethological analysis of the mouse open field test: effects of diazepam, chlordiazepoxide and an extremely low frequency pulsed magnetic field. Neurosci Biobehav Rev 25: 235-260.
42. Chudley AE, Kilgour AR, Cranston M, Edwards M. 2007. Challenges of diagnosis in fetal alcohol syndrome and fetal alcohol spectrum disorder in the adult. Am J Med Genet C Semin Med Genet 145C: 261-272.
43. Church MW, Kaltenbach JA. 1997. Hearing, speech, language, and vestibular disorders in the fetal alcohol syndrome: a literature review. Alcohol Clin Exp Res 21: 495-512.
44. Clarren SK, Smith DW. 1978. The fetal alcohol syndrome. N Engl J Med 298: 1063-1067.
45. Clay H, Ramakrishnan L. 2005. Multiplex fluorescent in situ hybridization in zebrafish embryos using tyramide signal amplification. Zebrafish 2: 105-111.
46. Craig MP, Gilday SD, Hove JR. 2006. Dose-dependent effects of chemical immobilization on the heart rate of embryonic zebrafish. Lab Anim (NY) 35: 41-47.
47. Dahm R, Geisler R. 2006. Learning from small fry: the zebrafish as a genetic model organism for aquaculture fish species. Mar Biotechnol (NY) 8: 329-345.
48. Dlugos CA, Rabin RA. 2003. Ethanol effects on three strains of zebrafish: model system for genetic investigations. Pharmacol Biochem Behav 74: 471-480.
49. Dlugos CA, Rabin RA. 2007. Ocular deficits associated with alcohol exposure during zebrafish development. J Comp Neurol 502: 497-506.
50. Dooley KA, Fraenkel PG, Langer NB, et al. 2008. Montalcino, a zebrafish model for variegate porphyria. Exp Hematol 36: 1132-1142.
51. Dove A. 1999. Drug screening-beyond the bottleneck. Nat Biotechnol 17: 859-863.
52. Drapeau P, Saint-Amant L, Buss RR, et al. 2002. Development of the locomotor network in zebrafish. Prog Neurobiol 68: 85-111.
53. Dutton K, Abbas L, Spencer J, et al. 2009. A zebrafish model for Waardenburg syndrome type IV reveals diverse roles for Sox10 in the otic vesicle. Dis Model Mech 2: 68-83.
54. Ellett F, Pase L, Hayman JW, et al. 2011. mpeg1 promoter transgenes direct macrophage-lineage expression in zebrafish. Blood 117: e49-e56.
55. Emran F, Rihel J, Dowling JE. 2008. A behavioral assay to measure responsiveness of zebrafish to changes in light intensities. J Vis Exp 20. pii: 923. doi: 10.3791/923.
56. Falk-Petersen IB. 2005. Comparative organ differentiation during early life stages of marine fish. Fish Shellfish Immunol 19: 397-412.
57. Fernandes Y, Gerlai R. 2009. Long-term behavioral changes in response to early developmental exposure to ethanol in zebrafish. Alcohol Clin Exp Res 33: 601-609.
58. Fleming A, Jankowski J, Goldsmith P. 2010. In vivo analysis of gut function and disease changes in a zebrafish larvae model of inflammatory bowel disease: a feasibility study. Inflamm Bowel Dis 16: 1162-1172.
59. Flinn L, Bretaud S, Lo C, et al. 2008. Zebrafish as a new animal model for movement disorders. J Neurochem 106: 1991-1997.
60. Forouhar AS, Hove JR, Calvert C, et al. 2004. Electrocardiographic characterization of embryonic zebrafish. Conf Proc IEEE Eng Med Biol Soc 5: 3615-3617.
61. Fraysse B, Mons R, Garric J. 2006. Development of a zebrafish 4-day embryo-larval bioassay to assess toxicity of chemicals. Ecotoxicol Environ Saf 63: 253-267.
62. Funfak A, Brosing A, Brand M, Kohler JM. 2007. Micro fluid segment technique for screening and development studies on Danio rerio embryos. Lab Chip 7: 1132-1138.
63. Gemma S, Vichi S, Testai E. 2007. Metabolic and genetic factors contributing to alcohol induced effects and fetal alcohol syndrome. Neurosci Biobehav Rev 31: 221-229.
64. George S, Xia T, Rallo R, et al. 2011. Use of a high-throughput screening approach coupled with in vivo zebrafish embryo screening to develop hazard ranking for engineered nanomaterials. ACS Nano 5: 1805-1817.
65. Gerlai R. 2003. Zebra fish: an uncharted behavior genetic model. Behav Genet 33: 461-468.
66. Gerlai R. 2010a. High-throughput behavioral screens: the first step towards finding genes involved in vertebrate brain function using zebrafish. Molecules 15: 2609-2622.
67. Gerlai R. 2010b. Zebrafish antipredatory responses: a future for translational research? Behav Brain Res 207: 223-231.
68. Gerlai R, Lahav M, Guo S, Rosenthal A. 2000. Drinks like a fish: zebra fish (Danio rerio) as a behavior genetic model to study alcohol effects. Pharmacol Biochem Behav 67: 773-782.
69. Giles S, Boehm P, Brogan C, Bannigan J. 2008. The effects of ethanol on CNS development in the chick embryo. Reprod Toxicol 25: 224-230.
70. Goedhart J, van WL, Hink MA, et al. 2010. Bright cyan fluorescent protein variants identified by fluorescence lifetime screening. Nat Methods 7: 137-139.
71. Goldsmith P. 2004. Zebrafish as a pharmacological tool: the how, why and when. Curr Opin Pharmacol 4: 504-512.
72. Gorge G, Nagel R. 1990. Toxicity of lindane, atrazine, and deltamethrin to early life stages of zebrafish (Brachydanio rerio). Ecotoxicol Environ Saf 20: 246-255.
73. Gray C, Loynes CA, Whyte MK, et al. 2011. Simultaneous intravital imaging of macrophage and neutrophil behavior during inflammation using a novel transgenic zebrafish. Thromb Haemost 105: 811-819.
74. Grossman L, Utterback E, Stewart A, et al. 2010. Characterization of behavioral and endocrine effects of LSD on zebrafish. Behav Brain Res 214: 277-284.
75. Grunwald DJ, Eisen JS. 2002. Headwaters of the zebrafish-emergence of a new model vertebrate. Nat Rev Genet 3: 717-724.
76. Guo S. 2004. Linking genes to brain, behavior and neurological diseases: what can we learn from zebrafish? Genes Brain Behav 3: 63-74.
77. Guo S. 2009. Using zebrafish to assess the impact of drugs on neural development and function. Expert Opin Drug Discov 4: 715-726.
78. Gutman DA, Nemeroff CB. 2003. Persistent central nervous system effects of an adverse early environment: clinical and preclinical studies. Physiol Behav 79: 471-478.
79. Haffter P, Granato M, Brand M, et al. 1996. The identification of genes with unique and essential functions in the development of the zebrafish, Danio rerio. Development 123: 1-36.
80. Haldi M, Ton C, Seng WL, McGrath P. 2006. Human melanoma cells transplanted into zebrafish proliferate, migrate, produce melanin, form masses and stimulate angiogenesis in zebrafish. Angiogenesis 9: 139-151.
81. Halle W. 2003. The Registry of Cytotoxicity: toxicity testing in cell cultures to predict acute toxicity (LD50) and to reduce testing in animals. Altern Lab Anim 31: 89-198.
82. Hascoet M, Bourin M, Dhonnchadha BA. 2001. The mouse light-dark paradigm: a review. Prog Neuropsychopharmacol Biol Psychiatry 25: 141-166.
83. Hasler G, Drevets WC, Manji HK, Charney DS. 2004. Discovering endophenotypes for major depression. Neuropsychopharmacology 29: 1765-1781.
84. Hassel D, Scholz EP, Trano N, et al. 2008. Deficient zebrafish ether-a-go-go-related gene channel gating causes short-QT syndrome in zebrafish reggae mutants. Circulation 117: 866-875.
85. Heim C, Newport DJ, Mletzko T, et al. 2008. The link between childhood trauma and depression: insights from HPA axis studies in humans. Psychoneuroendocrinology 33: 693-710.
86. Heim C, Plotsky PM, Nemeroff CB. 2004. Importance of studying the contributions of early adverse experience to neurobiological findings in depression. Neuropsychopharmacology 29: 641-648.
87. Henriquez NV, van Overveld PG, Que I, et al. 2007. Advances in optical imaging and novel model systems for cancer metastasis research. Clin Exp Metastasis 24: 699-705.
88. Henry BL, Minassian A, Young JW, et al. 2010. Cross-species assessments of motor and exploratory behavior related to bipolar disorder. Neurosci Biobehav Rev 34: 1296-1306.
89. Hermsen SA, van den Brandhof EJ, van der Ven LT, Piersma AH. 2011. Relative embryotoxicity of two classes of chemicals in a modified zebrafish embryotoxicity test and comparison with their in vivo potencies. Toxicol In Vitro 25: 745-753.
90. Hill AJ, Teraoka H, Heideman W, Peterson RE. 2005. Zebrafish as a model vertebrate for investigating chemical toxicity. Toxicol Sci 86: 6-19.
91. Hisaoka KK. 1958. The effects of 2-acetylaminofluorene on the embryonic development of the zebrafish. II. Histochemical studies. Cancer Res 18: 664-667.
92. Holsboer F. 2000. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 23: 477-501.
93. Hsieh CS, Ko CY, Chen SY, et al. 2008. In vivo long-term continuous observation of gene expression in zebrafish embryo nerve systems by using harmonic generation microscopy and morphant technology. J Biomed Opt 13: 064041.
94. Irons TD, Macphail RC, Hunter DL, Padilla S. 2010. Acute neuroactive drug exposures alter locomotor activity in larval zebrafish. Neurotoxicol Teratol 32: 84-90.
95. Jones KL, Smith DW. 1973. Recognition of the fetal alcohol syndrome in early infancy. Lancet 302: 999-1001.
96. Kaijzel EL, van der Pluijm G, Lowik CW. 2007. Whole-body optical imaging in animal models to assess cancer development and progression. Clin Cancer Res 13: 3490-3497.
97. Kallai J, Makany T, Csatho A, et al. 2007. Cognitive and affective aspects of thigmotaxis strategy in humans. Behav Neurosci 121: 21-30.
98. Kallai J, Makany T, Karadi K, Jacobs WJ. 2005. Spatial orientation strategies in Morris-type virtual water task for humans. Behav Brain Res 159: 187-196.
99. Kari G, Rodeck U, Dicker AP. 2007. Zebrafish: an emerging model system for human disease and drug discovery. Clin Pharmacol Ther 82: 70-80.
100. Kashyap B, Frederickson LC, Stenkamp DL. 2007. Mechanisms for persistent microphthalmia following ethanol exposure during retinal neurogenesis in zebrafish embryos. Vis Neurosci 24: 409-421.
101. Kavsek M, Bornstein MH. 2010. Visual habituation and dishabituation in preterm infants: a review and meta-analysis. Res Dev Disabil 31: 951-975.
102. Keller PJ, Schmidt AD, Santella A, et al. 2010. Fast, high-contrast imaging of animal development with scanned light sheet-based structured-illumination microscopy. Nat Methods 7: 637-642.
103. Keller PJ, Schmidt AD, Wittbrodt J, Stelzer EH. 2008. Reconstruction of zebrafish early embryonic development by scanned light sheet microscopy. Science 322: 1065-1069.
104. Kimmel CB, Ballard WW, Kimmel SR, et al. 1995. Stages of embryonic development of the zebrafish. Dev Dyn 203: 253-310.
105. Kokel D, Bryan J, Laggner C, et al. 2010. Rapid behavior-based identification of neuroactive small molecules in the zebrafish. Nat Chem Biol 6: 231-237.
106. Kokel D, Peterson RT. 2008. Chemobehavioral phenomics and behavior-based psychiatric drug discovery in the zebrafish. Brief Funct Genomic Proteomic 7: 483-490.
107. Kremers GJ, Goedhart J, van Munster EB, Gadella TWJr. 2006. Cyan and yellow super fluorescent proteins with improved brightness, protein folding, and FRET Forster radius. Biochemistry 45: 6570-6580.
108. Kumar K, Ansari BA. 1986. Malathion toxicity: effect on the liver of the fish Brachydanio rerio (Cyprinidae). Ecotoxicol Environ Saf 12: 199-205.
109. Labrot F, Narbonne JF, Ville P, et al. 1999. Acute toxicity, toxicokinetics, and tissue target of lead and uranium in the clam Corbicula fluminea and the worm Eisenia fetida: comparison with the fish Brachydanio rerio. Arch Environ Contam Toxicol 36: 167-178.
110. Langheinrich U, Vacun G, Wagner T. 2003. Zebrafish embryos express an orthologue of HERG and are sensitive toward a range of QT-prolonging drugs inducing severe arrhythmia. Toxicol Appl Pharmacol 193: 370-382.
111. Lanzky PF, Halling-Sorensen B. 1997. The toxic effect of the antibiotic metronidazole on aquatic organisms. Chemosphere 35: 2553-2561.
112. Lee KJ, Nallathamby PD, Browning LM, et al. 2007. In vivo imaging of transport and biocompatibility of single silver nanoparticles in early development of zebrafish embryos. ACS Nano 1: 133-143.
113. Levin ED, Bencan Z, Cerutti DT. 2007. Anxiolytic effects of nicotine in zebrafish. Physiol Behav 90: 54-58.
114. Lieschke GJ, Currie PD. 2007. Animal models of human disease: zebrafish swim into view. Nat Rev Genet 8: 353-367.
115. Liu H, Rigamonti D, Badr A, Zhang J. 2011. Ccm1 regulates microvascular morphogenesis during angiogenesis. J Vasc Res 48: 130-140.
116. Lockwood B, Bjerke S, Kobayashi K, Guo S. 2004. Acute effects of alcohol on larval zebrafish: a genetic system for large-scale screening. Pharmacol Biochem Behav 77: 647-654.
117. Lopez Patino MA, Yu L, Yamamoto BK, Zhdanova IV. 2008. Gender differences in zebrafish responses to cocaine withdrawal. Physiol Behav 95: 36-47.
118. Lopez-Patino MA, Yu L, Cabral H, Zhdanova IV. 2008. Anxiogenic effects of cocaine withdrawal in zebrafish. Physiol Behav 93: 160-171.
119. Loucks E, Carvan MJIII. 2004. Strain-dependent effects of developmental ethanol exposure in zebrafish. Neurotoxicol Teratol 26: 745-755.
120. Loucks EJ, Ahlgren SC. 2009. Deciphering the role of Shh signaling in axial defects produced by ethanol exposure. Birth Defects Res A Clin Mol Teratol 85: 556-567.
121. Ma AC, Fan A, Ward AC, et al. 2009. A novel zebrafish jak2a(V581F) model shared features of human JAK2(V617F) polycythemia vera. Exp Hematol 37: 1379-1386.
122. Macphail RC, Brooks J, Hunter DL, et al. 2009. Locomotion in larval zebrafish: influence of time of day, lighting and ethanol. Neurotoxicology 30: 52-58.
123. Martins J, Oliva TL, Vasconcelos V. 2007. Assays with Daphnia magna and Danio rerio as alert systems in aquatic toxicology. Environ Int 33: 414-425.
124. Matsui JI, Egana AL, Sponholtz TR, et al. 2006. Effects of ethanol on photoreceptors and visual function in developing zebrafish. Invest Ophthalmol Vis Sci 47: 4589-4597.
125. Maximino C, da Silva AW, Gouveia AJr., Herculano AM. 2011. Pharmacological analysis of zebrafish (Danio rerio) scototaxis. Prog Neuropsychopharmacol Biol Psychiatry 35: 624-631.
126. Maximino C, de Brito TM, Colmanetti R, et al. 2010a. Parametric analyses of anxiety in zebrafish scototaxis. Behav Brain Res 210: 1-7.
127. Maximino C, Marques de BT, Dias CA, et al. 2010b. Scototaxis as anxiety-like behavior in fish. Nat Protoc 5: 209-216.
128. McGrath P, Li CQ. 2008. Zebrafish: a predictive model for assessing drug-induced toxicity. Drug Discov Today 13: 394-401.
129. McKinley ET, Baranowski TC, Blavo DO, et al. 2005. Neuroprotection of MPTP-induced toxicity in zebrafish dopaminergic neurons. Brain Res Mol Brain Res 141: 128-137.
130. Meaney MJ. 2010. Epigenetics and the biological definition of gene × environment interactions. Child Dev 81: 41-79.
131. Meijer AH, Spaink HP. 2011. Host-pathogen interactions made transparent with the zebrafish Model. Curr Drug Targets. In press.
132. Milan DJ, Peterson TA, Ruskin JN, et al. 2003. Drugs that induce repolarization abnormalities cause bradycardia in zebrafish. Circulation 107: 1355-1358.
133. Mittelstadt SW, Hemenway CL, Craig MP, Hove JR. 2008. Evaluation of zebrafish embryos as a model for assessing inhibition of hERG. J Pharmacol Toxicol Methods 57: 100-105.
134. Mizell M, Romig ES. 1997. The aquatic vertebrate embryo as a sentinel for toxins: zebrafish embryo dechorionation and perivitelline space microinjection. Int J Dev Biol 41: 411-423.
135. Moore ES, Ward RE, Wetherill LF, et al. 2007. Unique facial features distinguish fetal alcohol syndrome patients and controls in diverse ethnic populations. Alcohol Clin Exp Res 31: 1707-1713.
136. Morris JA. 2009. Zebrafish: a model system to examine the neurodevelopmental basis of schizophrenia. Prog Brain Res 179: 97-106.
137. Mullins MC, Hammerschmidt M, Haffter P, Nusslein-Volhard C. 1994. Large-scale mutagenesis in the zebrafish: in search of genes controlling development in a vertebrate. Curr Biol 4: 189-202.
138. Muto A, Orger MB, Wehman AM, et al. 2005. Forward genetic analysis of visual behavior in zebrafish. PLoS Genet 1: e66.
139. Nei M, Xu P, Glazko G. 2001. Estimation of divergence times from multiprotein sequences for a few mammalian species and several distantly related organisms. Proc Natl Acad Sci USA 98: 2497-2502.
140. Nüsslein-Volhard 2002. The morphology of larval and adult zebrafish. In: Nüsslein-Volhard C, Dahm R, editors. Zebrafish: a pratical approach. Tubingen: Oxford University Press. pp. 59-94.
141. Organisation for Economic Cooperation and Development. 1998. OECD 212. Guideline for testing of chemicals. Fish, short-term toxicity test on embryo and sac-fry stages. France: Organisation for Economic Cooperation and Development.
142. Pariante CM. 2003. Depression, stress and the adrenal axis. J Neuroendocrinol 15: 811-812.
143. Parng C, Roy NM, Ton C, et al. 2007. Neurotoxicity assessment using zebrafish. J Pharmacol Toxicol Methods 55: 103-112.
144. Parng C, Seng WL, Semino C, McGrath P. 2002. Zebrafish: A preclinical model for drug screening. Assay Drug Dev Technol 1: 41-48.
145. Pather S, Gerlai R. 2009. Shuttle box learning in zebrafish (Danio rerio). Behav Brain Res 196: 323-327.
146. Peal DS, Mills RW, Lynch SN, et al. 2011. Novel chemical suppressors of long QT syndrome identified by an in vivo functional screen. Circulation 123: 23-30.
147. Perry W, Minassian A, Paulus MP, et al. 2009. A reverse-translational study of dysfunctional exploration in psychiatric disorders: from mice to men. Arch Gen Psychiatry 66: 1072-1080.
148. Peterson KJ, Lyons JB, Nowak KS, et al. 2004. Estimating metazoan divergence times with a molecular clock. Proc Natl Acad Sci USA 101: 6536-6541.
149. Pogoda HM, Hammerschmidt M. 2009. How to make a teleost adenohypophysis: molecular pathways of pituitary development in zebrafish. Mol Cell Endocrinol 312: 2-13.
150. Postlethwait JH, Woods IG, Ngo-Hazelett P, et al. 2000. Zebrafish comparative genomics and the origins of vertebrate chromosomes. Genome Res 10: 1890-1902.
151. Prut L, Belzung C. 2003. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol 463: 3-33.
152. Pugach EK, Li P, White R, Zon L. 2009. Retro-orbital injection in adult zebrafish. J Vis Exp 34 p ii: 1645. doi: 10.3791/1645.
153. Redfern WS, Waldron G, Winter MJ, et al. 2008. Zebrafish assays as early safety pharmacology screens: paradigm shift or red herring? J Pharmacol Toxicol Methods 58: 110-117.
154. Reimers MJ, Flockton AR, Tanguay RL. 2004. Ethanol- and acetaldehyde-mediated developmental toxicity in zebrafish. Neurotoxicol Teratol 26: 769-781.
155. Reimers MJ, La Du JK, Periera CB, et al. 2006. Ethanol-dependent toxicity in zebrafish is partially attenuated by antioxidants. Neurotoxicol Teratol 28: 497-508.
156. Richards FM, Alderton WK, Kimber GM, et al. 2008. Validation of the use of zebrafish larvae in visual safety assessment. J Pharmacol Toxicol Methods 58: 50-58.
157. Rihel J, Prober DA, Arvanites A, et al. 2010. Zebrafish behavioral profiling links drugs to biological targets and rest/wake regulation. Science 327: 348-351.
158. Roche H, Boge G, Peres G. 1994. Acute and chronic toxicities of colchicine in Brachydanio rerio. Bull Environ Contam Toxicol 52: 69-73.
159. Rodriguez F, Lopez JC, Vargas JP, et al. 2002. Spatial memory and hippocampal pallium through vertebrate evolution: insights from reptiles and teleost fish. Brain Res Bull 57: 499-503.
160. Rostand A, Kaminski M, Lelong N, et al. 1990. Alcohol use in pregnancy, craniofacial features, and fetal growth. J Epidemiol Community Health 44: 302-306.
161. Rubinstein AL. 2003. Zebrafish: from disease modeling to drug discovery. Curr Opin Drug Discov Dev 6: 218-223.
162. Sawle AD, Wit E, Whale G, Cossins AR. 2010. An information-rich alternative, chemicals testing strategy using a high definition toxicogenomics and zebrafish (Danio rerio) embryos. Toxicol Sci 118: 128-139.
163. Schaaf MJ, Champagne D, van Laanen IH, et al. 2008. Discovery of a functional glucocorticoid receptor beta-isoform in zebrafish. Endocrinology 149: 1591-1599.
164. Schaaf MJ, Koopmans WJ, Meckel T, et al. 2009. Single-molecule microscopy reveals membrane microdomain organization of cells in a living vertebrate. Biophys J 97: 1206-1214.
165. Scholz EP, Niemer N, Hassel D, et al. 2009. Biophysical properties of zebrafish ether-a-go-go related gene potassium channels. Biochem Biophys Res Commun 381: 159-164.
166. Selderslaghs IW, Hooyberghs J, De CW, Witters HE. 2010. Locomotor activity in zebrafish embryos: a new method to assess developmental neurotoxicity. Neurotoxicol Teratol 32: 460-471.
167. Selderslaghs IW, Van Rompay AR, De CW, Witters HE. 2009. Development of a screening assay to identify teratogenic and embryotoxic chemicals using the zebrafish embryo. Reprod Toxicol 28: 308-320.
168. Serra EL, Medalha CC, Mattioli R. 1999. Natural preference of zebrafish (Danio rerio) for a dark environment. Braz J Med Biol Res 32: 1551-1553.
169. Sharma R, Tsuchiya M, Tannous BA, Bartlett JD. 2011. Measurement of fluoride-induced endoplasmic reticulum stress using gaussia luciferase. Methods Enzymol 491: 111-125.
170. Sharma S, Coombs S, Patton P, Burt de PT. 2009. The function of wall-following behaviors in the Mexican blind cavefish and a sighted relative, the Mexican tetra (Astyanax). J Comp Physiol A Neuroethol Sens Neural Behav Physiol 195: 225-240.
171. Shen YC, Li D, Al-Shoaibi A, et al. 2009. A student team in a University of Michigan biomedical engineering design course constructs a microfluidic bioreactor for studies of zebrafish development. Zebrafish 6: 201-213.
172. Shin JT, Fishman MC. 2002. From zebrafish to human: modular medical models. Annu Rev Genomics Hum Genet 3: 311-340.
173. Shu X, Shaner NC, Yarbrough CA, et al. 2006. Novel chromophores and buried charges control color in mFruits. Biochemistry 45: 9639-9647.
174. Simon P, Dupuis R, Costentin J. 1994. Thigmotaxis as an index of anxiety in mice. Influence of dopaminergic transmissions. Behav Brain Res 61: 59-64.
175. Sison M, Cawker J, Buske C, Gerlai R. 2006. Fishing for genes influencing vertebrate behavior: zebrafish making headway. Lab Anim (NY) 35: 33-39.
176. Sousa N, Almeida OF, Wotjak CT. 2006. A hitchhiker's guide to behavioral analysis in laboratory rodents. Genes Brain Behav 5(Suppl 2): 5-24.
177. Spaink HP, Bagowski CP. 2009.PCT/IB2008/002918 [WO/2009/056961]. The Netherlands.
178. Spaink HP, Dirks RPH. 2011.High throughput method and system for in vivo screening. EP20090164956 [WO2011/005094]. Leiden.
179. Spence R, Gerlach G, Lawrence C, Smith C. 2008. The behavior and ecology of the zebrafish, Danio rerio. Biol Rev Camb Philos Soc 83: 13-34.
180. Spohr HL, Willms J, Steinhausen HC. 2007. Fetal alcohol spectrum disorders in young adulthood. J Pediatr 150: 175-179.
181. Steenbergen PJ, Richardson MK, Champagne DL. 2010. The use of the zebrafish model in stress research. Prog Neuropsychopharmacol Biol Psychiatry. In press.
182. Steenbergen PJ, Richardson MKChampagne D. 2011. Patterns of avoidance behaviors in the light/dark preference test in young juvenile zebrafish. Behav Brain Res 222: 15-25.
183. Stephenson JF, Whitlock KE, Partridge JC. 2011. Zebrafish preference for light or dark is dependent on ambient light levels and olfactory stimulation. Zebrafish 8: 17-22.
184. Stewart A, Wu N, Cachat J, et al. 2010. Pharmacological modulation of anxiety-like phenotypes in adult zebrafish behavioral models. Prog Neuropsychopharmacol Biol Psychiatry. In press.
185. Strack RL, Hein B, Bhattacharyya D, et al. 2009. A rapidly maturing far-red derivative of DsRed-Express2 for whole-cell labeling. Biochemistry 48: 8279-8281.
186. Stromland K, Pinazo-Duran MD. 2002. Ophthalmic involvement in the fetal alcohol syndrome: clinical and animal model studies. Alcohol Alcohol 37: 2-8.
187. Sun J, Liu J, Tu W, Xu C. 2010. Separation and aquatic toxicity of enantiomers of the organophosphorus insecticide O-ethyl O-4-nitrophenyl phenylphosphonothioate (EPN). Chemosphere 81: 1308-1313.
188. Suster ML, Kikuta H, Urasaki A, et al. 2009. Transgenesis in zebrafish with the tol2 transposon system. Methods Mol Biol 561: 41-63.
189. Tanguay RL, Reimers MJ. 2008. Analysis of ethanol developmental toxicity in zebrafish. Methods Mol Biol 447: 63-74.
190. Telfer WR, Busta AS, Bonnemann CG, et al. 2010. Zebrafish models of collagen VI-related myopathies. Hum Mol Genet 19: 2433-2444.
191. Teraoka H, Dong W, Hiraga T. 2003. Zebrafish as a novel experimental model for developmental toxicology. Congenit Anom (Kyoto) 43: 123-132.
192. Ton C, Lin Y, Willett C. 2006. Zebrafish as a model for developmental neurotoxicity testing. Birth Defects Res A Clin Mol Teratol 76: 553-567.
193. Tran TC, Sneed B, Haider J, et al. 2007. Automated, quantitative screening assay for antiangiogenic compounds using transgenic zebrafish. Cancer Res 67: 11386-11392.
194. Treit D, Fundytus M. 1988. Thigmotaxis as a test for anxiolytic activity in rats. Pharmacol Biochem Behav 31: 959-962.
195. Tropepe V, Sive HL. 2003. Can zebrafish be used as a model to study the neurodevelopmental causes of autism? Genes Brain Behav 2: 268-281.
196. Truong L, Harper SL, Tanguay RL. 2011. Evaluation of embryotoxicity using the zebrafish model. Methods Mol Biol 691: 271-279.
197. Tsang M. 2010. Zebrafish: a tool for chemical screens. Birth Defects Res C Embryo Today 90: 185-192.
198. United States Environmental Protection Agency. 2002. Methods for measuring the acute toxicity of effluents and receiving waters to freshwater and marine organisms (EPA-821-R-02-012). Washington, DC: United States Environmental Protection Agency. 30 p.
199. United States Environmental Protection Agency. 1996. Ecological effects test guidelines: OPPTS 850.1075: fish acute toxicity test, freshwater and marine. Washington, DC: United States Environmental Protection Agency. pp. 1-11.
200. Van den Belt K, Van Puymbroeck S, Witters H. 2000. Toxicity of cadmium-contaminated clay to the zebrafish Danio rerio. Arch Environ Contam Toxicol 38: 191-196.
201. Veldman MB, Lin S. 2008. Zebrafish as a developmental model organism for pediatric research. Pediatr Res 64: 470-476.
202. Verkman AS. 2004. Drug discovery in academia. Am J Physiol Cell Physiol 286: C465-C474.
203. Wang W, Liu X, Gelinas D, et al. 2007. A fully automated robotic system for microinjection of zebrafish embryos. PLoS ONE 2: e862.
204. Wattendorf DJ, Muenke M. 2005. Fetal alcohol spectrum disorders. Am Fam Physician 72: 279-282, 285.
205. Welten MC, de Haan SB, van den Boogert N, et al. 2006. Zebrafish: fluorescent in situ hybridization protocol and three-dimensional imaging of gene expression patterns. Zebrafish 3: 465-476.
206. Westerfield, M. The Zebrafish Book. A guide for the laboratory use of zebrafish (Danio rerio). 4th ed. 2000. Eugene: University of Oregon Press.
207. Winter MJ, Redfern WS, Hayfield AJ, et al. 2008. Validation of a larval zebrafish locomotor assay for assessing the seizure liability of early-stage development drugs. J Pharmacol Toxicol Methods 57: 176-187.
208. Wong BK, Hossain SM, Trinh E, et al. 2010. Hyperactivity, startle reactivity and cell-proliferation deficits are resistant to chronic lithium treatment in adult Nr2e1(frc/frc) mice. Genes Brain Behav 9: 681-694.
209. Yang F, Zhang Q, Guo H, Zhang S. 2010. Evaluation of cytotoxicity, genotoxicity and teratogenicity of marine sediments from Qingdao coastal areas using in vitro fish cell assay, comet assay and zebrafish embryo test. Toxicol In Vitro 24: 2003-2011.
210. Yang L, Ho NY, Alshut R, et al. 2009. Zebrafish embryos as models for embryotoxic and teratological effects of chemicals. Reprod Toxicol 28: 245-253.
211. Zok S, Gorge G, Kalsch W, Nagel R. 1991. Bioconcentration, metabolism and toxicity of substituted anilines in the zebrafish (Brachydanio rerio). Sci Total Environ 109-110: 411-421.
212. Zon LI, Peterson RT. 2005. In vivo drug discovery in the zebrafish. Nat Rev Drug Discov 4: 35-44.